dockets: FDA-2026-P-12607

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2026-P-12607 FDA Requests that the FDA declare that the drug product Diclofenac Sodium Topical Solution, 1.95%, is suitable for consideration in an Abbreviated New Drug Application. Nonrulemaking 2026-10-15T20:48:15Z 0b000064b9672ab1                     list_pull

Links from other tables